Sunstone Life Science Ventures logo

Sunstone Life Science Ventures

Europe, Hovedstaden, Denmark, Copenhagen

Description

Sunstone Life Science Ventures is a European, early-stage VC investing in novel pharmaceutical ingredients for human therapeutic use

Investor Profile

Sunstone Life Science Ventures has made 59 investments, with 0 in the past 12 months and 15% as lead.

Stage Focus

  • Series Unknown (25%)
  • Series A (24%)
  • Series B (17%)
  • Series C (15%)
  • Seed (5%)
  • Post Ipo Equity (3%)
  • Series D (3%)
  • Pre Seed (2%)
  • Private Equity (2%)
  • Debt Financing (2%)

Country Focus

  • Denmark (44%)
  • Switzerland (14%)
  • United States (12%)
  • Sweden (7%)
  • Germany (3%)
  • The Netherlands (3%)
  • Finland (3%)
  • United Kingdom (3%)
  • France (3%)
  • Ireland (3%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Therapeutics
  • Pharmaceutical
  • Life Science
  • Genetics
  • Health Diagnostics
  • Wellness
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Sunstone Life Science Ventures frequently co-invest with?

Wellington Partners
Europe, Bayern, Germany, Munich
Co-Investments: 5
Omega Funds
Europe, Geneve, Switzerland, Geneva
Co-Investments: 5
Ysios Capital
Europe, Pais Vasco, Spain, San Sebastian
Co-Investments: 6
Seventure Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 5
Forbion Capital Partners
Europe, Noord-Holland, The Netherlands, Naarden
Co-Investments: 7
Atlas Venture
North America, Massachusetts, United States, Cambridge
Co-Investments: 5
Industrifonden
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 6
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 16
Kurma Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 7
M Ventures
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 5

Which angels does Sunstone Life Science Ventures often collaborate with?

TM
Europe, Hovedstaden, Denmark, Copenhagen
Shared Deals: 1
JY
North America, California, United States, San Francisco
Shared Deals: 1
CS
North America, California, United States, Truckee
Shared Deals: 1
RZ
Europe, England, United Kingdom, London
Shared Deals: 1

What are some of recent deals done by Sunstone Life Science Ventures?

Resalis Therapeutics

Torino, Piemonte, Italy

Resalis Therapeutics sviluppa un farmaco in grado di inibire un micro-RNA per il trattamento di alcune malattie metaboliche

BiotechnologyClinical TrialsHealth CareMedicalPharmaceuticalProduct ResearchTherapeutics
Series AJan 4, 2024
Amount Raised: $10,947,495
Kynexis

Naarden, Noord-Holland, The Netherlands

Kynexis is advancing the first potential precision medicine for the treatment of cognitive impairment associated with schizophrenia (CIAS).

BiotechnologyHealth CareMedicalTherapeutics
Series ANov 7, 2023
Amount Raised: $60,970,914
Minervax

Hellerup, Hovedstaden, Denmark

Minervax is a biotechnology company developing a novel vaccine against Group B Streptococcus.

BiotechnologyHealth CareLife ScienceMedicalWellness
Series UnknownOct 11, 2023
Amount Raised: $57,367,288
DiogenX

Marseille, Provence-Alpes-Cote d'Azur, France

DiogenX is a preclinical stage biotech company specializing in the development of pancreatic beta-cell modulators.

BiotechnologyLife Science
Series AMay 10, 2023
Amount Raised: $36,792,809
Teitur Trophics

Aarhus, Midtjylland, Denmark

Teitur Trophics is a biotech company developing novel treatments for neurodegenerative diseases.

BiotechnologyLife ScienceMedical
Series AMar 14, 2023
Amount Raised: $30,034,765
Rewind Therapeutics

Antwerp, Antwerpen, Belgium

Rewind Therapeutics is a developer of novel therapeutics intended to facilitate the treatment for neurological diseases.

BiotechnologyTherapeutics
Series AJan 25, 2023
Minervax

Hellerup, Hovedstaden, Denmark

Minervax is a biotechnology company developing a novel vaccine against Group B Streptococcus.

BiotechnologyHealth CareLife ScienceMedicalWellness
Series CDec 15, 2022
Amount Raised: $23,405,251
TargED Biopharmaceuticals

Utrecht, Utrecht, The Netherlands

TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.

BiopharmaBiotechnologyHealth CarePharmaceutical
Series AFeb 19, 2022
Amount Raised: $44,156,009
Step Pharma

Paris, Ile-de-France, France

Step Pharma is a biotechnology company.

BiotechnologyPharmaceutical
Series BMar 24, 2021
Amount Raised: $41,345,159
Ascelia Pharma

Malmö, Skane Lan, Sweden

Ascelia Pharma is a biotechnology company that provides novel drugs.

BiotechnologyHealth CareMedicalPharmaceutical
Post Ipo EquityMar 17, 2021
Amount Raised: $23,678,399